XML 60 R31.htm IDEA: XBRL DOCUMENT
v3.22.4

License and Collaboration Agreements - Additional Information (Details) - USD ($) $ in Thousands | 1 Months Ended | 12 Months Ended
--- | --- | ---
May 31, 2022 | Dec. 31, 2022 | Dec. 31, 2021
License and Collaboration Agreements [Line Items] |  |  |
Research and development |  | $ 40,689 | $ 26,909
License Agreement | Sanofi |  |  |
License and Collaboration Agreements [Line Items] |  |  |
Upfront payment | $ 3,000 |  |
Aggregate development and regulatory milestone payments |  | 43,000 |
Obligation to payment upon maximum achievement of certain clinical and commercial milestones |  | 150,000 |
License Agreement | License Rights | Sanofi |  |  |
License and Collaboration Agreements [Line Items] |  |  |
Transaction costs associated with asset acquisition |  | 100 |
IPR&D | License Agreement | License Rights | Sanofi |  |  |
License and Collaboration Agreements [Line Items] |  |  |
Research and development |  | $ 3,100 |

X
- Definition Aggregate development and regulatory milestone payments. + References No definition available. + Details
Name: | rlyb_AggregateDevelopmentAndRegulatoryMilestonePayments
Namespace Prefix: | rlyb_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Asset acquisition transaction costs incurred. + References No definition available. + Details
Name: | rlyb_AssetAcquisitionTransactionCosts
Namespace Prefix: | rlyb_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition License and collaboration agreements. + References No definition available. + Details
Name: | rlyb_LicenseAndCollaborationAgreementsLineItems
Namespace Prefix: | rlyb_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Obligation to payment upon maximum achievement of certain clinical and commercial milestones + References No definition available. + Details
Name: | rlyb_ObligationToPaymentUponMaximumAchievementOfCertainClinicalAndCommercialMilestones
Namespace Prefix: | rlyb_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Upfront payment + References No definition available. + Details
Name: | rlyb_UpfrontPayment
Namespace Prefix: | rlyb_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 912 -SubTopic 730 -Section 25 -Paragraph 1 -URI https://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 985 -SubTopic 20 -Section 50 -Paragraph 1 -URI https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 730 -SubTopic 10 -Section 50 -Paragraph 1 -URI https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373 + Details
Name: | us-gaap_ResearchAndDevelopmentExpense
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Details
Name: | srt_ProductOrServiceAxis=rlyb_LicenseAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=rlyb_SanofiMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AssetAcquisitionAxis=rlyb_LicenseRightsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |